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Abstract: Alterations of the β-adrenergic signalling, structural remodelling, and electrical failure
of T-tubules are hallmarks of heart failure (HF). Here, we assess the effect of β-adrenoceptor
activation on local Ca2+ release in electrically coupled and uncoupled T-tubules in ventricular
myocytes from HF rats. We employ an ultrafast random access multi-photon (RAMP) microscope to
simultaneously record action potentials and Ca2+ transients from multiple T-tubules in ventricular
cardiomyocytes from a HF rat model of coronary ligation compared to sham-operated rats as a
control. We confirmed that β-adrenergic stimulation increases the frequency of Ca2+ sparks, reduces
Ca2+ transient variability, and hastens the decay of Ca2+ transients: all these effects are similarly
exerted by β-adrenergic stimulation in control and HF cardiomyocytes. Conversely, β-adrenergic
stimulation in HF cells accelerates a Ca2+ rise exclusively in the proximity of T-tubules that regularly
conduct the action potential. The delayed Ca2+ rise found at T-tubules that fail to conduct the action
potential is instead not affected by β-adrenergic signalling. Taken together, these findings indicate
that HF cells globally respond to β-adrenergic stimulation, except at T-tubules that fail to conduct
action potentials, where the blunted effect of the β-adrenergic signalling may be directly caused by
the lack of electrical activity.
Keywords: heart failure; T-tubules; excitation-contraction coupling; β-adrenergic signalling;
non-linear microscopy imaging
1. Introduction
In cardiomyocytes, stimulation of β-adrenergic receptors (β-AR) activates a powerful positive
inotropic response via cAMP-dependent protein kinase A (PKA). PKA phosphorylates several key
proteins that modulate cardiac function: L-type Ca2+ channels (LTCC) [1], ryanodine receptors
(RyR2) [2], phospholamban [3], troponin I [4], and myosin-binding protein-C [5]. In heart failure
(HF), one of the first causes of death worldwide [6], the β-AR system is compromised both in
human and animal models [7–10], namely due to downregulation of mRNA and protein levels
of β1-AR [11,12], one of the two main receptor isoforms that are present in the heart [13]. Moreover,
HF is characterized by a plethora of (mal)adaptive mechanisms leading to myocardial remodelling [14].
Int. J. Mol. Sci. 2016, 17, 1471; doi:10.3390/ijms17091471 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2016, 17, 1471 2 of 10
Among those, HF distinguishes for ultrastructural and functional alterations of the transverse-axial
tubular system (T-tubules), the complex sarcolemma invagination network that synchronously
triggers action potentials (AP) in cardiac cells [15]. The two main isoforms of β-adrenergic receptors
(β1 and β2-ARs) are both expressed on the T-tubular membrane and exert their function on the
local excitation-contraction (EC) coupling machinery via cAMP and PKA [16]. However, the relative
contribution of the two maladaptive processes, i.e., impairment of β-AR signalling and T-tubular
defects, to the altered cardiomyocyte response to catecholamines remains undetermined.
Furthermore, beyond the alteration and loss of the T-tubular structure [17,18] observed in
pathological settings, we recently demonstrated that electrical defects can occur even though the
T-tubule structure is maintained [19], and cause compromised Ca2+ release [20]. With the present
work, we assess the subcellular local Ca2+ release after acute β-AR stimulation in HF, in light of the
new findings demonstrating the presence of T-tubular electrical defects that directly impair local Ca2+
release [20].
2. Results
2.1. Action Potentials and Ca2+ Transients in Failing Cells Treated with Isoproterenol
We previously demonstrated [19] that the HF rat model is characterized by the co-presence
of electrically uncoupled and electrically coupled T-tubules, named AP− and AP+, respectively.
This electrical defect profoundly impacts the local Ca2+ release [20]. Here, we find that isoproterenol
does not restore the function of uncoupled T-tubules. In fact, HF cells acutely exposed to 10−7 M
isoproterenol show 5.6% ± 3% of AP− (n = 265 from 55 cells, nine animals), in line with our previous
findings in HF cells at basal conditions [19,20]. In Figure 1B, we report representative voltage traces
(in red) and the corresponding Ca2+ transients (in cyan) recorded from AP+ and AP− T-tubules in
the absence (Figure 1A, HF) and presence of isoproterenol (HF + ISO). The effect of β-AR stimulation
on the Ca2+ rise in correspondence to AP+ tubules is qualitatively different from that observed in
AP− elements. In fact, the expected reduction of Ca2+ transient time-to-peak (TTP) after isoproterenol
is observed exclusively in the proximity of AP+, while Ca2+ transient TTP of AP− is not affected
by isoproterenol treatment (Figure 1C). On the contrary, the 50% decay of Ca2+ transients (CaT50)
is significantly hastened in HF + ISO cardiomyocytes as compared with HF cells at basal condition
at both AP+ and AP− sites. These results suggest that the Ca2+ transient detected at AP− tubules
results from the Ca2+ signal propagating from neighbouring sites, and the velocity of propagation is
not regulated by β-AR signalling. Contrarily, the increased phosphorylation of phospholamban by
PKA activation is preserved, increasing the sarcoplasmic reticulum Ca2+ ATPase (SERCA) reuptake
rate across the whole cardiomyocyte, at both AP+ and AP− sites.
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Figure 1. Ca2+ transient in HF cells treated with isoproterenol. (A) Two-photon fluorescence (TPF) 
image of a stained rat failing ventricular myocyte: sarcolemma in red (di-4-ANE(F)PTEA) and [Ca2+]i 
in cyan (GFP-certified Fluoforte). Scale bar: 5 μm. On the right, a two-fold magnification of the region 
in the white dashed box. The lines mark the probed T-tubule (TT) sites: TT1 and TT2; (B) Average of 
10 subsequent fluorescence traces (ΔF/F0) recorded from two scanned sites in a heart failure (HF) cell 
and in an isoproterenol-treated HF cell (HF + ISO, 10–7 M). AP is elicited at 200 ms (black arrowheads). 
Membrane voltage (red) and [Ca2+]i (cyan); (C) Graphs showing Ca2+ release time-to-peak (TTP) and 
50% decay (CaT50) in HF and HF + ISO cells. The failing TTs (AP−) have been distinguished from the 
electrically responsive ones (AP+). Data from 86 HF cells (506 AP+ and 23 AP−, n = 9), and from 55  
HF + ISO cells (265 AP+ and 15 AP−, n = 9). Asterisks indicate significant differences (Student’s t-test,  
** p < 0.01, *** p < 0.001). Ochre and magenta lines represent the Ca2+ kinetics features measured nearby 
TTs of, respectively, CTRL and of isoproterenol-treated CTRL (CTRL + ISO) cells: mean (solid) ± SE 
(dashed). CTRL and CTRL + ISO data from previously published data [20]. Ochre and magenta 
asterisks refer to the comparison with CTRL or CTRL + ISO values, respectively. 
2.2. Spatio-Temporal Variability of Ca2+ Transients in Isoproterenol-Treated Failing Cardiomyocytes 
By studying multiple T-tubule sites within the same cell, we can assess the variability of Ca2+ 
transients both in time (beat-to-beat; at the same site) and in space (among different sites). A 
coefficient of variability (CV) is calculated as σ/μ, where σ is the standard deviation and μ is the 
mean. The CV of Ca2+ release is calculated based on time (beat-to-beat CV) and space (spatial CV) and 
the corresponding graphs are reported in Figure 2B,C. We previously demonstrated that even in 
CTRL cardiomyocytes, T-tubules display a non-negligible beat-to-beat and spatial variability of the 
rate of Ca2+ release; such variability is significantly reduced with isoproterenol application [20]. In HF 
cells, the CV of TTP is significantly higher than that of the CTRL in the vicinity of both AP+ and AP−. 
Ca2+ decay of failing cardiomyocytes is also more variable when compared to CTRL cells. In  
Figure 2A, we superimposed three subsequent Ca2+ traces recorded in three different T-tubules of  
a HF and HF + ISO myocyte. It can be noticed that isoproterenol application reduces the variability 
of local Ca2+ release and reuptake in HF cells and, as reported in the columns (Figure 2B,C), the 
variability of every parameter in HF + ISO is similar to that observed in CTRL + ISO cardiomyocytes. 
The synchronizing effect of β-AR treatment on Ca2+ transients is likely due to enhanced RyR2 
recruitment by increased channel phosphorylation [21]. 
2.4. Isoproterenol Effect on Ca2+ Sparks Frequency in Heart Failure 
To further evaluate β-AR’s role on RyR open probability (Po), we studied the Ca2+ spark 
frequency. Ca2+ sparks are defined as spontaneous Ca2+ release events occurring at a single Ca2+ 
release unit (CRU) [22] during a regularly paced sequence of Ca2+ transients. Here, we confirmed that 
the Ca2+ sparks frequency during diastole is dramatically increased after isoproterenol treatment in 
control cardiomyocytes, their frequency being 1.8 ± 1.8 mHz and 32.9 ± 5.4 mHz, without and with 
isoproterenol treatment, respectively. In Figure 3A, we reported two representative fluorescence 
Figure 1. Ca2+ transient in HF cells treated with isoproterenol. (A) Two-photon fluorescence (TPF)
image of a stained rat failing ventricular myocyte: sarcolemma in red (di-4-ANE(F)PTEA) and [Ca2+]i
in cyan (GFP-certified Fluoforte). Scale bar: 5 µm. On the right, a two-fold magnification of the region
in the white dashed box. The lines mark the probed T-tubule (TT) sites: TT1 and TT2; (B) Average of
10 subsequent fluorescence traces (∆F/F0) recorded from two scanned sites in a heart failure (HF) cell
and in an isoproterenol-treated HF cell (HF + ISO, 10–7 M). AP is elicited at 200 ms (black arrowheads).
Membrane voltage (red) and [Ca2+]i (cyan); (C) Graphs showing Ca2+ release time-to-peak (TTP) and
50% decay (CaT50) in HF and HF + ISO cells. The failing TTs (AP−) have been distinguished from
the electrically responsive ones (AP+). Data from 86 HF cells (506 AP+ and 23 AP−, n = 9), and from
55 HF + ISO cells (265 AP+ and 15 AP−, n = 9). Asterisks indicate significant differences (Student’s t-test,
** p < 0.01, *** p < 0.001). Ochre and magenta lines represent the Ca2+ kinetics features measured nearby
TTs of, respectively, CTRL and of isoproterenol-treated CTRL (CTRL + ISO) cells: mean (solid) ± SE
(dashed). CTRL and CTRL + ISO data from previously published data [20]. Ochre and magenta
asterisks refer to the comparison with CTRL or CTRL + ISO values, respectively.
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variability is significantly reduced with isoproterenol application [20]. In HF cells, the CV of TTP is
significantly higher than that of the CTRL in the vicinity of both AP+ and AP−. Ca2+ decay of failing
cardiomyocytes is also more variable when compared to CTRL cells. In Figure 2A, we superimposed
three subsequent Ca2+ traces recorded in three different T-tubules of a HF and HF + ISO myocyte. It can
be noticed that isoproterenol application reduces the variability of local Ca2+ release and reuptake in
HF cells and, as reported in the columns (Figure 2B,C), the variability of every parameter in HF + ISO is
similar to that observed in CTRL + ISO cardiomyocytes. The synchronizing effect of β-AR treatment on
Ca2+ transients is likely due to enhanced RyR2 recruitment by increased channel phosphorylation [21].
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To further evaluate β-AR’s role on RyR open probability (Po), we studied the Ca2+ spark frequency.
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HF cardiomyocytes (bottom). In HF, we previously reported a significantly augmented Ca2+ sparks
frequency in isolated cardiomyocytes [20] as compared to the control. Our result did not depend on
the electrical activity of the corresponding T-tubule. In fact, electrically coupled T-tubules and failing
elements displayed similarly increased levels of Ca2+ sparks in their vicinity. Here, the isoproterenol
treatment of HF cardiomyocytes significantly enhances the frequency of Ca2+ sparks in AP+ (Figure 3C)
as compared to CTRL cells treated with isoproterenol. In line with previous results [20], AP− elements
show the same tendency after isoproterenol treatment. This result suggests that HF cells respond
to β-adrenergic signalling with an augmented Ca2+ leakage from the sarcoplasmic reticulum (SR)
similarly to CTRL cells, irrespective of T-tubule excitability.
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CV. Asterisks indicate significant differences (Student’s t-test, * p < 0.05, *** p < 0.001). Data from 86 
HF cells (506 AP+ and 23 AP−, n = 9), and from 55 HF + ISO cells (265 AP+ and 15 AP−, n = 9). Ochre 
and magenta lines represent the Ca2+ transient CV features measured nearby TTs of, respectively, 
CTRL and of isoproterenol-treated CTRL (CTRL + ISO): mean (solid) ± SE (dashed). CTRL data from 
previously published data [20]. Ochre and magenta asterisks refer to the comparison with CTRL or 
CTRL + ISO values, respectively. 
Figure 2. Spatio-temporal variability of Ca2+ transient in HF cells treated with isoproterenol.
(A) Superposition of three subsequent Ca2+ transients recorded in three different T-tubules (TTi)
of HF and HF + ISO cardiomyocytes; (B,C) Graphs showing Ca2+ release coefficient of variability (CV)
calculated at time-to-peak (TTP) and 50% Ca2+ transient decay (CaT50) based on time (beat-to-beat CV)
and on space (spatial CV). AP+ and AP− HF and HF + ISO are separately analysed in beat-to-beat CV.
Asterisks indicate significant differences (Student’s t-test, * p < 0.05, *** p < 0.001). Data from 86 HF
cells (506 AP+ and 23 AP−, n = 9), and from 55 HF + ISO cells (265 AP+ and 15 AP−, n = 9). Ochre and
magenta lines represent the Ca2+ transient CV features measured nearby TTs of, respectively, CTRL and
of isoproterenol-treated CTRL (CTRL + ISO): mean (solid) ± SE (dashed). CTRL data from previously
published data [20]. Ochre and magenta asterisks refer to the comparison with CTRL or CTRL + ISO
values, respectively.
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ISO), respectively: mean (solid) ± SE (dashed). CTRL data from previously published data [20]. Ochre 
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stimulation of β-AR signalling increases Ca2+ sparks frequency [25] in intact control cardiomyocytes. 
In HF, β-AR signalling is disrupted, leading to an excessive phosphorylation of RyR [2] and decreased 
binding of RyR to its regulatory protein FKBP12.6 [26]. These modifications are, however, 
accompanied by decreased activity of SERCA as well as increased activity of NCX, eventually 
determining reduced SR load. In such a scenario, it is complicated to predict whether the Ca2+ sparks 
rate is changed in HF compared to control cells. Previous work by Gomez et al. did not observe an 
increased frequency of Ca2+ sparks in failing rat cardiomyocytes [27], while an augmented SR Ca2+ 
leak has been found in intact ventricular myocytes of failing rabbits [28]. In the present work, Ca2+ 
sparks are increased compared to the control in the absence of β-AR stimulation. The factors 
influencing RyR gating have been extensively reviewed [29,30], the major culprits being probably the 
RyR phosphorylation performed by the calcium-calmodulin–dependent protein kinase (CaMKII) [31] 
and other post-translational modifications of RyR2 found in HF [32,33]. PKA-dependent 
phosphorylation of RyR does not seem to increase the RyR leak [34]. After β-AR stimulation, we 
found that the Ca2+ sparks frequency is increased in HF cardiomyocytes similarly to isoproterenol-
treated control cells. This finding suggests that β-AR signalling still has leeway to generate Ca2+ 
sparks in HF cells, using the same mechanisms of control cells (i.e., increased RyR2 open probability 
and SR Ca2+ load). In addition, the microenvironment pertinent to failing T-tubules shows a Ca2+ 
sparks rate comparable to that of electrically coupled elements and displays a similar response to  
β-AR stimulation. 
Figure 3. Ca2+ sparks in HF cells treated with isoproterenol. (A) Two representative fluorescence traces
(∆F/F0) recorded from HF and HF + ISO cells. The grey arrow pinpoints Ca2+ sparks occurrence;
(B) Columns showing mean Ca2+ sparks frequency (fs) recorded in AP+ and AP− from HF and
HF + ISO myocytes. Asterisks indicate significant differences (Student’s t-test, * p < 0.05 ** p < 0.01).
Data from 86 HF cells (506 AP+ and 23 AP−, n = 9), and from 55 HF + ISO cells (265 AP+ and 15 AP−,
n = 9). Ochre and magenta lines represent the (fs) measured in CTRL and of isoproterenol-treated CTRL
(CTRL + ISO), respectively: mean (solid)± SE (dashed). CTRL data from previously published data [20].
Ochre and magenta asterisks refer to the comparison with CTRL or CTRL + ISO values, respectively.
3. Discussion
In the present work, we employ an optical technique capable of simultaneously studying Ca2+
and voltage at a sub-cellular level, in order to disclose the effects of β-AR signalling on Ca2+ release at
the local level in failing rat cardiomyocytes. As demonstrated by our investigations on Ca2+ sparks
and Ca2+ transient variability, we find that acute stimulation of the β-AR system increases the open
probability (Po) of RyR channels by a similar extent in HF cells and control cardiomyocytes. It is of note
that the RAMP microscope has a sensitivity capable of detecting single Ca2+ sparks [20], by probing a
volume that contains about 5–10 CRUs (~10 µm3) [23,24]. In our work, Ca2+ sparks are not evoked by
cellular permeabilization or specifically designed stimulation protocols, but occur spontaneously in
intact cardiomyocytes during regular pacing at steady state. We confirmed that stimulation of β-AR
signalling increases Ca2+ sparks frequency [25] in intact control cardiomyocytes. In HF, β-AR signalling
is disrupted, leading to an excessive phosphorylation of RyR [2] and decreased binding of RyR to
its regulatory protein FKBP12.6 [26]. These modifications are, however, accompanied by decreased
activity of SERCA as well as increased activity of NCX, eventually determining reduced SR load. In
such a scenario, it is complicated to predict whether the Ca2+ sparks rate is changed in HF compared
to control cells. Previous work by Gomez et al. did not observe an increased frequency of Ca2+
sparks in failing rat cardiomyocytes [27], while an augmented SR Ca2+ leak has been found in intact
ventricular myocytes of failing rabbits [28]. In the present work, Ca2+ sparks are increased compared
to the control in the absence of β-AR stimulation. The factors influencing RyR gating have been
extensively reviewed [29,30], the major culprits being probably the RyR phosphorylation performed
by the calcium-calmodulin–dependent protein kinase (CaMKII) [31] and other post-translational
modifications of RyR2 found in HF [32,33]. PKA-dependent phosphorylation of RyR does not seem
to increase the RyR leak [34]. After β-AR stimulation, we found that the Ca2+ sparks frequency
is increased in HF cardiomyocytes similarly to isoproterenol-treated control cells. This finding
suggests that β-AR signalling still has leeway to generate Ca2+ sparks in HF cells, using the same
mechanisms of control cells (i.e., increased RyR2 open probability and SR Ca2+ load). In addition,
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the microenvironment pertinent to failing T-tubules shows a Ca2+ sparks rate comparable to that of
electrically coupled elements and displays a similar response to β-AR stimulation.
Moreover, we observe a synchronization of RyR2 recruitment upon β-AR challenge as
demonstrated by the coefficient of variability of Ca2+ transients. In fact, a homogeneous recruitment of
RyR2 operated by β-AR signalling is observed both in space and in time and it is similar in failing and
CTRL cardiomyocytes after isoproterenol challenge. Altogether, these observations allow inferring
that, despite altered basal levels, the β-AR signalling on RyR2 is well preserved in HF cells.
Alterations of Ca2+ release have been previously observed in HF cells with structurally remodelled
T-tubules [35,36] and wall stress progressively determines the level of structural disruption and
the consequences on Ca2+ release [37]. Although the lack of T-tubules represents a perturbation
of Ca2+ handling per se, here we focused on the microenvironment around preserved T-tubules.
Employing a novel functional imaging technique [38], we have demonstrated that about 6% of
T-tubules fail to propagate AP in HF [19,20] and the entity of this defect can be much larger in
other pathologies, e.g., 22.7% ± 5% in mice carrying a mutation associated with hypertrophic
cardiomyopathy [39]. Such T-tubular electrical failure exerts a major impact on the Ca2+ rise in HF [20]
which has to be added to the abnormal Ca2+ release previously observed. In HF cardiomyocytes, the
AP failure prevents LTCC activation, because, even though β-AR signalling phosphorylates LTCC,
this response does not translate into higher sarcolemmal Ca2+ influx or into the downstream SR
Ca2+ release. In fact, shortening of the Ca2+ transient TTP is reduced by β-AR activation exclusively
in the vicinity of electrically coupled T-tubules (AP+). The acceleration of Ca2+ transient TTP after
β-AR stimulation in HF cells is lower than in control cardiomyocytes. This can be explained by
the fact that HF cardiomyocytes show a lower density of LTCC but a higher level of basal Ca2+
channel phosphorylation [40], likely limiting the ability of β-AR activation to further augment
LTCC. In addition, β-AR stimulation in HF has been associated with the impaired formation of
E-C coupling microdomains [41] that may further reduce the β-AR signalling role on LTCC. It is of
note that β-AR stimulation speeds up Ca2+ transient decay at every location in HF cells. It means that
β-AR–mediated phosphorylation of phospholamban is maintained in the cardiomyocyte, increasing
the SERCA reuptake rate across the whole cell. Again, this is the hint that β-AR machinery is still
capable of working in failing cardiomyocytes when the target substrates are present.
In conclusion, our work provides functional information about the subcellular responsiveness to
β-AR signalling in HF that should be integrated in the complex scenario of the β-adrenergic molecular
modifications found in this disease. Here, we provide evidence that a novel mechanism for the blunted
β-AR signalling is present in HF and it does not directly involve receptors and downstream effectors,
but it is caused by the absence of electrical activity in some T-tubules.
4. Materials and Methods
4.1. Cardiomyocyte Preparations and Labelling
Ventricular myocytes were isolated from male Wistar Han rats (300–350 g, Harlan Laboratories
SRL) as previously described [19]. Myocardial infarction is induced by ligation of the left anterior
coronary artery as previously described [18]. In this class of experiments male Wistar Han
rats (190–230 g, Harlan Laboratories SRL) were used. Cardiac function was monitored with
echocardiography before surgery and was periodically checked after the intervention. Six weeks
after the infarction, a left ventricular dilatation occurs, together with a loss of contractile function.
Echocardiographic data have been previously reported [20]. In details, we measured the end-diastolic
diameter (EDD) and the end-systolic diameter (ESD) in four CTRL and 18 HF rats. We found that
the left-ventricular fractional shortening calculated as (EDD–ESD)/EDD in percentage is significantly
decrease. Moreover, HF rats showed arrhythmias during the echocardiographic procedure that have
never been observed in CTRL. Student’s t-test applied. Rats were sacrificed six to eight weeks after
surgery and used for cell isolation. All animal procedures are performed conform the guidelines from
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Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific
purposes; experimental protocol is approved by the Italian Ministry of Health on the 6th of July
2015 (approved protocol number 647/2015-PR). Cells were loaded in extracellular buffer added with
10 µM blebbistatin, 4 µM cytochalasin D, and 500 µM CaCl2. First, 0.5 µg/mL of GFP-certified
Fluoforte dissolved in DMSO were added to the cell suspension for 15 min. After washing, 2 µg/mL of
di-4-AN(F)EPPTEA dissolved in ethanol was also added for 15 min and then cells were resuspended
in fresh extracellular buffer containing 10 µM blebbistatin, 4 µM cytochalasin D and 1 mM CaCl2.
Loaded preparations were used for experiments within 1 h. Although blebbistatin is known to be fairly
safe [42], cytochalasin D was found to exert a slight effect on Ca2+ transient at 40 µM [43]. For this
reason, to avoid any artifact in measurements, we applied cytochalasin D in all experimental groups at
a quite low concentration. The staining and imaging session were performed at room temperature
(20 ◦C).
4.2. RAMP Microscope and Optical Recording
The basic design of our RAMP imaging system has been already described [20]. Briefly, it consists
of a 1064 nm fiber laser, an acousto-optic modulator for angular spreading pre-compensation and
two orthogonally mounted acousto-optic deflectors for laser scanning. The fluorescence signal was
collected in backward direction by the excitation oil immersion objective (63 × NA 1.4; Zeiss) and
in forward direction using a high numerical aperture condenser lens. For each detection direction,
a dichroic mirror was used to split the two spectral components of the fluorescence signal, the red and
the green emission light. The fluorescence signal was detected by two independent photon counting
modules based on GaAsP photomultiplier tube (H7422, Hamamatsu). Emission filters of 655 ± 20 nm
and 520 ± 16 nm were used for voltage and Ca2+ detection, respectively. The measurements were
performed during steady-state stimulation (0.34 Hz). The cells were field-stimulated using two parallel
platinum wires (250 µm in diameter) placed at a distance of 6.3 mm. Square pulses of 10–20 V and
duration of 3 ms were used to reach AP threshold. In a typical measurement, we probed 5–10 different
sarcolemmal sites for ten subsequent trials. The length of the scanned lines ranged from 2 to 10 µm
with an integration time per membrane pass of ~200 µs, leading to a temporal resolution of 0.4–2 ms.
The large Stokes shift of fluorinated VSD is not sufficient to prevent spectral contamination between
the two channels. For this reason, we optimized a simple un-mixing procedure under two hypotheses:
negligible contamination of the green channel on the red one and constant VSD sensitivity across the
emission spectrum.
4.3. Data Analysis and Statistics
Optical data were analysed with software written in LabVIEW 2010 (National Instruments).
The amplitude and kinetics parameters of the Ca2+ were manually identified trace by trace for the
calculation of the coefficient of variation (CV), while the mean values of each probed site were
determined after averaging 10 subsequent trials to increase accuracy. Spontaneous Ca2+ sparks were
scored when a sudden increase of fluorescence intensity occurred with a ∆F/F0 two-fold above
the trace noise not correlated to the electrical stimulus. Ca2+ spark frequency was normalized
to time and excitation volume (sparks·pl−1·s−1), assuming the two-photon excitation volume as
VTPE = pi3/2ωxωyωz/0.68, where (ω) is 1/e widths of the lateral (xy) and axial (z) intensity squared
profiles [44]. An average length of 6 µm is used for the scanned lines. VSD sensitivity was estimated
based on the evidence that AP amplitude of 100 mV corresponds to a fluorescence variation of 20%.
The T-tubules showing failures were scored using threshold ∆F/F0 = 0.037 in agreement with our
previous finding [19]. In order to analyse diastolic Ca2+ sparks, we calculated the systole as the CaT95
for each experimental group, the rest of the recording is considered diastole. Data are expressed
and plotted as means ± SEM (Standard Error of Mean) obtained from a number of independent
determinations on different myocytes. Number of cells and number of animals (N) are indicated in
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the figure legends for each set of measurements. Unpaired Student’s t-test is used for comparisons.
A p-value of < 0.05 is considered statistically significant (* p < 0.05, ** p < 0.01, *** p < 0.001).
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